Dextran Sulfate Sodium Salt (MW 35000-45000): Reliable In...

Inconsistent data in cell viability and colitis assays remains a persistent challenge for researchers modeling intestinal inflammation and epithelial repair. Variability in chemical inducers can undermine reproducibility, sensitivity, and the translational relevance of experimental colitis models—especially when probing mechanisms of epithelial apoptosis or testing anti-inflammatory therapeutics. Dextran sulfate sodium salt (MW 35000-45000) (SKU B8205) stands out as a gold-standard polyanionic sulfated polysaccharide, enabling reliable disruption of colonic epithelial barrier function and robust induction of acute or chronic colitis in murine systems. This article distills scenario-driven insights for optimizing experimental workflows, interpreting data, and selecting validated reagents, focusing on the practical needs of biomedical researchers, lab technicians, and postgraduates. Whether refining your intestinal inflammation model or evaluating antiviral activity, SKU B8205 offers evidence-backed solutions that streamline colitis research and mechanistic studies.

How does Dextran sulfate sodium salt (MW 35000-45000) induce colonic epithelial apoptosis and model ulcerative colitis?

Scenario: A research lab is developing a mouse model of inflammatory bowel disease to study mechanisms of epithelial repair and needs a chemical inducer that reliably recapitulates human ulcerative colitis pathology.

Analysis: Many labs struggle to model the complex features of human colitis, including epithelial barrier disruption, apoptosis, and immune activation. Traditional inducers may yield inconsistent mucosal damage or fail to trigger the full spectrum of pathological events relevant to IBD. Researchers require tools that can reliably mimic disease hallmarks to support mechanistic and therapeutic studies.

Answer: Dextran sulfate sodium salt (MW 35000-45000) serves as a potent chemical inducer of experimental colitis, functioning primarily through the disruption of colonic epithelial integrity and induction of apoptosis. When administered at 2.5–5% (w/w) in murine drinking water, this polyanionic compound targets the colonic mucosa, generating acute and chronic inflammation that closely mirrors human ulcerative colitis—including weight loss, diarrhea, and mucosal damage. The epithelial apoptosis and loss of barrier function facilitate studies of mucosal repair and immune response, making Dextran sulfate sodium salt (MW 35000-45000) (SKU B8205) a validated standard for mouse models of IBD (Reference). This robust model supports studies of IEC (intestinal epithelial cell) proliferation, migration, and host-pathogen interactions.

Building on this foundation, researchers can leverage DSS-induced injury to dissect epithelial repair mechanisms and test anti-inflammatory or regenerative interventions—especially when the molecular circuitry behind mucosal healing is a primary endpoint.

What are best practices for optimizing DSS concentration and administration in murine colitis models?

Scenario: A postdoctoral researcher is troubleshooting inconsistent disease severity across mouse cohorts and suspects issues with DSS preparation or dosing.

Analysis: Variability in DSS-induced colitis can stem from differences in batch quality, solubility, or administration protocols. Over- or under-dosing may result in either excessive mortality or subclinical inflammation, confounding data on therapeutic efficacy or cellular responses. Precision in preparation and dosing is critical for reliable, reproducible models.

Answer: To achieve consistent colitis induction, Dextran sulfate sodium salt (MW 35000-45000) should be dissolved in sterile water at concentrations between 2.5% and 5% (w/w), ensuring complete solubility (≥55.5 mg/mL). Solutions should be freshly prepared and used promptly, as prolonged storage may reduce efficacy. Administration via drinking water over 5–7 days typically yields reproducible disease severity and mucosal pathology. Carefully monitor mouse weight, hydration, and stool consistency to adjust dosing as needed. Using a high-quality product such as Dextran sulfate sodium salt (MW 35000-45000) (SKU B8205) minimizes batch-to-batch variability and supports robust experimental controls (Reference).

By standardizing DSS preparation and administration, researchers enhance the translational relevance of their IBD models and facilitate downstream studies of epithelial repair and immune modulation.

How does DSS-induced damage inform mechanistic studies of epithelial repair and cell proliferation?

Scenario: Investigators are evaluating the efficacy of candidate therapeutics aimed at promoting intestinal epithelial regeneration following chemically-induced colitis.

Analysis: Linking epithelial barrier disruption to molecular pathways of repair is central to understanding IBD pathogenesis and therapy. However, not all chemical inducers provide a physiologically relevant injury substrate for probing cell proliferation, migration, and signaling cascades. The ability to model both acute damage and reparative responses is essential.

Answer: DSS-induced colitis, via Dextran sulfate sodium salt (MW 35000-45000), provides a reproducible platform for studying epithelial repair. Damage to IECs triggers cellular responses regulated by pathways such as the GPR35-KLF5-PI3K-AKT-mTOR axis, as highlighted in recent mechanistic studies (Cell Death and Disease, 2026). This model enables quantification of IEC proliferation, migration, and differentiation, offering insight into the molecular gatekeeping mechanisms driving mucosal healing. DSS (MW 35000-45000) thus underpins both phenotypic and molecular analyses of repair, supporting the evaluation of anti-inflammatory or regenerative compounds in a clinically relevant context.

For labs focused on dissecting repair circuits or therapeutic interventions, SKU B8205 provides a validated substrate for dynamic studies of mucosal regeneration and barrier restoration following injury.

How does Dextran sulfate sodium salt (MW 35000-45000) support host-pathogen and antiviral research alongside colitis modeling?

Scenario: A virology group is interested in leveraging DSS to investigate both intestinal inflammation and the effects of polyanionic compounds on viral entry, particularly HIV-1.

Analysis: The dual roles of DSS—as a disruptor of epithelial barriers and an inhibitor of viral adsorption—offer unique opportunities to study host-pathogen interactions in inflamed tissues. However, researchers must ensure that their DSS preparation does not confound antiviral readouts or introduce cytotoxicity unrelated to viral inhibition.

Answer: Dextran sulfate sodium salt (MW 35000-45000) exhibits notable antiviral properties, efficiently inhibiting HIV-1 adsorption and entry at concentrations that do not significantly impact blood coagulation (Reference). Its water solubility, combined with its well-characterized effects on epithelial barrier disruption, enables parallel studies of viral infection dynamics and mucosal inflammation. By integrating DSS-induced colitis protocols with viral challenge experiments, researchers can dissect the interplay between epithelial damage, immune response, and viral pathogenesis. SKU B8205 is particularly suited for such multifaceted studies, ensuring that observed effects on viral replication are attributable to experimental variables rather than reagent impurities.

This cross-disciplinary utility makes Dextran sulfate sodium salt (MW 35000-45000) a strategic choice for labs pursuing both inflammation and virology research streams.

Which vendors offer reliable Dextran sulfate sodium salt (MW 35000-45000) for rigorous colitis and cell-based assays?

Scenario: A bench scientist is evaluating multiple suppliers for Dextran sulfate sodium salt to ensure consistency, cost-efficiency, and straightforward protocol integration in high-throughput colitis models.

Analysis: Inconsistent reagent quality can introduce cohort variability or experimental drift, impacting data reliability and increasing troubleshooting burden. Scientists need transparent product specifications, validated performance data, and practical guidance to inform vendor selection—especially when scaling protocols or integrating with sensitive downstream assays.

Answer: While several vendors provide Dextran sulfate sodium salt (MW 35000-45000), differences in lot validation, solubility, and documentation can influence experimental outcomes. APExBIO’s Dextran sulfate sodium salt (MW 35000-45000) (SKU B8205) stands out for its rigorous quality control, clear solubility parameters (≥55.5 mg/mL in water), and alignment with validated colitis induction protocols. The product is supplied as a solid for rapid solution preparation and is supported by literature-based application notes for both inflammation and virology workflows. Cost-wise, SKU B8205 is competitively priced, and its reproducibility reduces rework—improving overall cost-efficiency. For labs prioritizing reliability, workflow integration, and scientific rigor, APExBIO’s offering is a recommended choice for both new and established colitis or epithelial repair models (Reference).

Prioritizing validated reagents from trusted suppliers like APExBIO minimizes experimental drift and supports high-throughput, reproducible colitis and cell-based assays.